• A recent study highlights the critical health challenge posed by the co-infection of tuberculosis (TB) and COVID-19, which has been associated with higher fatality rates and more severe health outcomes.

• The study found TB-COVID co-infection prevalence rates of approximately 0.06% in South Africa and 0.02% in California, USA.

• The pooled fatality rate among co-infected patients was 7.1%, and the mean fatality rate for those hospitalized was 11.4%.

• Health professionals are raising concerns about the dual threat that COVID-19 co-infection and tuberculosis (TB) pose.

• This study suggests that patients suffering from both TB and COVID-19 may experience worse health outcomes and an increased risk of death compared to those with either condition alone.

• The study emphasizes the need for global collaboration to address the challenges of TB-COVID co-infection, especially in countries with limited medical resources.

• Continued research is crucial to understand and address TB-COVID co-infection challenges, as it remains prevalent with fatality rates higher than COVID-19 alone.

Click here to read more.